Dimopoulos, M., Richardson, P., & Lonial, S. (2022). Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma. Clinical lymphoma, myeloma and leukemia, 22(7), 460-473. https://doi.org/10.1016/j.clml.2022.01.011
Citace podle Chicago (17th ed.)Dimopoulos, Meletios-Athanasios, Paul Richardson, a Sagar Lonial. "Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma." Clinical Lymphoma, Myeloma and Leukemia 22, no. 7 (2022): 460-473. https://doi.org/10.1016/j.clml.2022.01.011.
Citace podle MLA (9th ed.)Dimopoulos, Meletios-Athanasios, et al. "Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma." Clinical Lymphoma, Myeloma and Leukemia, vol. 22, no. 7, 2022, pp. 460-473, https://doi.org/10.1016/j.clml.2022.01.011.